Member Info for Lp160606

Lol Grim I hope you don’t view gdr as 100/1 shot aha. Even in my sceptical view I’d offer much shorter odds ;)

They could remember their log in details then

ah, ears must of been burning.

Yes, it will in my view.

My interpretation is it is a lab system, system being the key thing here and will be touted as a US lab system for sure. Danahar - Beckman - Cytiva.

And it was lab based mechanisms that could file for exemption, i believe.

Reckon Technik or Safy can further clarify.

Tbf mate that response highlights your close minded approach to the organisation and is why you didn't look to disprove any of my points. Always good to consider all things, and all i did was articulate why people are frustrated with DB, me included. But as i also said, all will be forgiven if BC deliver.

I'll be sure to congratulate DB when/if he delivers regarding Beckman. Doesn't mean i can't disagree with some decisions/comments he has made prior to this.

You calling it an amazing deal is again so very naive. We do not yet truly understand the mechanics. Until profit margins, Lab sites, Test volumes & Contract lengths are released we can't say it is the Covid deal of the pandemic at all. But i do hope you are right.

100 billion on testing, aha they are off their heads in my view.

Great if we benefit but 100 billion seems a tad excessive to me.

Yep. 3rd day in a row with large buys.

News is on its way.

And don't even get me started on Walbrook lol

But seriously i know it might not read like it, we will be getting some good news in the next week imo

BigAl,

DB is the figurehead associated with GDR. Naturally that will be where frustrations are directed.

Although i know you do not agree with the criticism to not understand why people are critical of him is concerning, as it is extremely obvious to me how somebody could form that view.

Comparatively look at NCYT, AVCT & ODX. All 3 management teams provide regular updates. ODX particularly, when their SP dropped in half the CEO organised a presentation to inform and update Investors, and even improved their social presence due to investors requests.

You mention what would i like to be RNS'd, the fact he has nothing to RNS is the worry in itself lol. AVCT although some RNS may read as immaterial it keeps them known within the market, and entices new investors, I would take any of their CEOs over ours. Just watch 2 presentations of each company and compare them. DB, dead last in my view. Charisma of a wooden spoon, and say what you want, you need a showman when you are a 40 person business vying for market share.

Issued a placement at a 40% discount, then proceeded to spend very little of it within a 6 week window (we know this due to trading update showing 7 of the 8 mil still in the bank)..

Then the investor presentation. The vox one. He included a competitive analysis slide, slamming our competition. And yet, 0 RNS sales to date. Arrogance shown here in my view.

Then he sent thousands of samples to Italy, Germany & Spain. Yet didn't close a big enough sale to deliver us an RNS. Those 'european sales' how do we know they just are not paid for samples he sent out?

Received no update in 3 months on European supply chain he was supposedly setting up.

ICMR changing to DCGI then back again. A number of discrepancies on the website with Product specs.

Bottled his Sky interview.

So although you may not agree with the criticism BigAl, to not understand it is actually quite a blinded view.

Anyway, i'll be congratulating him in a few days and like i said, all will be forgiven. But mistakes have been made. To not understand that is naive.

Problem is BigAl we have been close to transformational news since the end of July.

David budd is deserving of Criticism in my view. Comms and PR are poor and the sales in June were not considered material enough to release to market. The venting in his direction is very fair in my view.

All will be forgiven should he deliver value to beckman. And I think GDR will deliver there.

We will know this time next week at the latest.

I understand the lack of interest here, the market need a proof point. Over the next 5 sessions I believe beckman will deliver this.

I’m not after ridiculous volumes, just initial success and expansion to a few over sites.

Now or never for David Budd.

Ok, that makes more sense tbf.

Thanks Phil.

Personally think it is nonsense. Why leave the 'draft' watermark on it if they were expecting approval and forward planning by uploading said document. Doesn't even make sense.

Magsy, I tend to agree with your posts but I believe this week is different.

That doc was not meaningfully on that website or certainly was not placed there in June upon submission. The date of the document is August for a start.

And so, it is new information to us and has answered a few of my unanswered questions for sure, I certainly feel more confident after reading the document.

I was of the view that failing approvals was certainly possible, especially icmr. This doc has eased those fears and I expect to receive fda in the coming weeks for sure which will also give us Indian access.

There has been little to shout about here over the last few months, literally been going off scraps. Got to celebrate the little wins.

Same company advisors who told me in writing we applied for DCGI when it was actually ICMR.

My trust is low with Walbrook.

Also, the document states August creation.

Not possible for it to of been live/unchanged for several weeks..

Hahaha ffs PHil.

Even so, we should be in for news regarding Beckman next week, good to bolster SP in anticipation for news.

Thanks mate!

No idea.

@Jay where on the webiste is the doc? Cant find it for love nor money without the direct URL.

Spot on Technick.

Jay inadvertently causing the bounce. lol